Atlas Trials

Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE

Clinical trial NCT05125094 · UNKNOWN

Trial details

NCT number
NCT05125094
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatocellular Carcinoma Stage III
Start date
2021-12-01
Primary completion
2024-07-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.